Skip to main content
RecallRadar
FDAClass II

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use… Recalled: Defective Delivery System: Possibility of no medication in the prefilled pen.

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled… was recalled on August 28, 2026 in cooperation with the U.S. Food and Drug Administration because defective Delivery System: Possibility of no medication in the prefilled pen..

Is my unit affected?

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Model, lot & date codes to check

Lot #: AP250095A, Exp 2/28/2027

Units affected: 5,694 pens

Where it was sold: USA Nationwide

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Defective Delivery System: Possibility of no medication in the prefilled pen.

Class II means the product might cause a temporary or medically reversible health problem; the chance of serious harm is remote.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: Amneal Pharmaceuticals of New York, LLC

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.